Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mostafa Moghaddam"'
Autor:
Mojgan Shaiegan, Mostafa Moghaddam, Mahtab Maghsudlu, Azita Azarkeivan, Sima Zolfaghari, Ali-Akbar Pourfatollah, Peyman Soleimanzadeh, Ehsan Shahverdi
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 16, Iss 1 (2022)
Background: An analysis of red blood cell alloimmunization in patients with thalassemia can help to devise specific strategies to decrease the alloimmunization rate. This study explored the frequency and specificity of alloantibodies and autoantibodi
Externí odkaz:
https://doaj.org/article/3e7a9a02b198429ab63828ad14879120
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 13, Iss 1 (2019)
Iran is a member of the International Society for Blood Transfusion (ISBT) working party on rare donors since 20102. Recognition of individuals with Rhnull phenotype was reported to the working party in order to be added to the list of countries with
Externí odkaz:
https://doaj.org/article/0c45401b023b4e7b921baa14f2857c30
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 12, Iss 3 (2018)
Rhnull phenotype is a rare blood group with a frequency of approximately 1 in 6 million individuals, transmitted via an autosomal recessive mode. It is characterized by the weak (Rh mod) or lack (Rh null) of expression of all Rh antigens on the red c
Externí odkaz:
https://doaj.org/article/d82955d9e4c24c82b7384ff65cbe048a
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 12, Iss 3 (2018)
Background: Over the past decades, interest in establishing a National Rare Donor Program has increased significantly worldwide. The experience of developing countries, however, is still limited. Rare blood is defined as a blood group found in a 1000
Externí odkaz:
https://doaj.org/article/a3b293426a674748a548a9bb37038633
Publikováno v:
Asian Journal of Transfusion Science, Vol 7, Iss 2, Pp 156-157 (2013)
Alloimmunization against the Rhesus-D (RhD) antigen still remains as a major cause of hemolytic disease of fetus and newborn (HDFN). Determination of paternal RhDzygosity is performed by molecular testing and is valuable for the management of alloimm
Externí odkaz:
https://doaj.org/article/dde15961bba24bb8ae87935fe7e3599f
Publikováno v:
Electronic Physician. 12:7791-7794
Publikováno v:
Vox Sanguinis. 114:256-261
Background and objectives In transfusion medicine, it may be a challenge to acquire compatible blood for patients who have clinically important alloantibodies to high-prevalence antigens. The aim of this study was to study prevalence of rare D-- phen
Autor:
Fatemeh Hassani, Mostafa Moghaddam, Ehsan Shahverdi, Bashir Hajbeigi, Ali Akbar Pourfathollah, Fahimeh Herfat
Publikováno v:
Transfusion Medicine and Hemotherapy. 46:376-380
Background: The lack of correct blood grouping practices can lead to missing of the rare Bombay Oh phenotype and subjecting patients to the risk of severe hemolytic transfusion reaction. In the absence of blood donor registry, transfusion management
Autor:
Mojgan Shaiegan, Mostafa Moghaddam, Mahtab Maghsudlu, Azita Azarkeivan, Sima Zolfaghari, Ali-Akbar Pourfatollah, Peyman Soleimanzadeh, Ehsan Shahverdi
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 16, Iss 1 (2022)
Background: An analysis of red blood cell alloimmunization in patients with thalassemia can help to devise specific strategies to decrease the alloimmunization rate. This study explored the frequency and specificity of alloantibodies and autoantibodi
Publikováno v:
Transfusion. 57:97-101
BACKGROUND The objective was to determine the frequency of occurrence of alloantibodies among pregnant women in Iran. STUDY DESIGN AND METHODS This was a prospective cross-sectional study, which was carried out in the immunohematology reference labor